TERRI BROWN: Open Payments
NPI 1376761106 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 7 payments from 5 companies in 2025. Trend: 2023 $291 · 2024 $316 · 2025 $652
Food & beverage: $633Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $269 |
| GENZYME CORPORATION | 1 | $126 |
| Lilly USA, LLC | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Ozempic, CEREZYME, Wegovy, ZEPBOUND, UZEDY, JARDIANCE.
Industry payments across MI — which companies pay providers there.
